CinDome Pharma
Latest round
- Series B
Last raised
- May 2024
Total raised
- $29M
Investors
- 2
About CinDome Pharma
Established in 2015 by CEO Jon Isaacsohn and based in Ohio, US, CinDome Pharma, Inc. is conducting research and developing the medication deudomperidone, which is used to treat persistent gastroparesis. In May 2024, CinDome Pharma, Inc. CinDome's primary pharmaceutical focus is the development of CIN-102, an engineered formulation of domperidone intended for the treatment of gastroparesis. This chronic condition causes delayed stomach emptying, leading to nausea, vomiting, and abdominal pain. CinDome Pharma's product pipeline includes CIN-109 and CIN-110: monotherapies targeting obesity through GDF-15 and PYY 3-36 analogs. CIN-209 and CIN-210: Combination treatments for obesity, leveraging dual agonists of GDF-15/GLP-1 and PYY 3-36/GLP-1. CIN-102: A dopamine 2/3 antagonist for gastroparesis with prokinetic and antiemetic effects. CIN-103: A formulation for IBS-D aimed at enhancing therapeutic exposure. CIN-108: An oncology treatment targeting defective cullin neddylation 1 (DCN1). TTP399: An adjunct therapy for type 1 diabetes. Neurodegenerative therapies: under development by Retromer Therapeutics.
Who invested in CinDome Pharma
2 investors across 1 round
See all investors in CinDome Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 16, 2024
Amount
$29M
Investors
Questions about CinDome Pharma
Who invested in CinDome Pharma?
CinDome Pharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CinDome Pharma raised?
CinDome Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CinDome Pharma last raise money?
CinDome Pharma's most recent round on record is a Series B, in May 2024.
What does CinDome Pharma do?
Established in 2015 by CEO Jon Isaacsohn and based in Ohio, US, CinDome Pharma, Inc.
Where is CinDome Pharma headquartered?
CinDome Pharma is headquartered in Cincinnati, US.
Which VCs invest in companies like CinDome Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at CinDome Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like CinDome Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.